Drug Trials Snapshots – HYMPAVZI

HYMPAVZI is a drug used to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A or hemophilia B. It is to be used in patients who have not developed an immune response known as factor VIII or factor IX inhibitors or antibody. Hemophilia A and hemophilia B…

Key Insights

• This topic is currently trending
• Experts are closely monitoring developments
• It may impact future decisions